In summary, our results provide a potential therapeutic strategy for NPC by disrupting the interaction of PKP1 and TIL-B cells in the TME and a theoretical basis for better understanding the mechanism of NPC development. The gene discussed is PKP1; the disease is nasopharyngeal carcinoma.